Back

Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders Valvular Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Muntadher Al Zaidi

University hospital Bonn, Bonn (Germany)

8 More presentations in this session

Presentation thumbnail
Discussant - Biomarkers, biomechanics, and innovations in valve and vascular disorders
Presentation thumbnail
Benefits of extubation after the Fontan operation: a theoretical analysis using serial patient-specific Fontan computational fluid dynamics models
Doctor K. Sughimoto (Chiba, JP)
Abstract Video
Presentation thumbnail
Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis
Doctor Y. Morimoto (Suita, JP)
Abstract Video
Presentation thumbnail
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
Ms K. Lee (Singapore, SG)
Abstract
Presentation thumbnail
A novel heart valve design reduces turbulence in aortic flow
Doctor S. Zheng (Bern, CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Acute heart failure and valvular heart disease
thumbnail
Congress Session
How to manage valvular heart disease in heart failure
thumbnail
Congress Presentation
Transcatheter therapies for structural heart disease: where are we in 2023?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources